A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BMM / bone marrow macrophages

[Related PubMed/MEDLINE]
Total Number of Papers: 55
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BMM  (>> Co-occurring Abbreviation)
Long Form:   bone marrow macrophages
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 CD55 Regulates Bone Mass in Mice by Modulating RANKL-Mediated Rac Signaling and Osteoclast Function. GPI, GTPase, M-CSF, RANKL, WT
2020 PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3beta-NFATc1 signaling cascade. PI3K, RANKL
2019 Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice. EVO, PMO, RANKL
2018 Ca2+-Dependent Regulation of NFATc1 via KCa3.1 in Inflammatory Osteoclastogenesis. RANKL
2018 Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis upon collagen treatment. MSC, OC
2018 Effects of retinoids on physiologic and inflammatory osteoclastogenesis in vitro. ATRA, RANKL
2018 PCSK9 induces a pro-inflammatory response in macrophages. hPCSK9, SMCs
2018 Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts. SP, TAC, WT
2017 Genetic deletion of the Rho GEF Net1 impairs mouse macrophage motility and actin cytoskeletal organization. ---
10  2017 Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-kappaB ligand-induced osteoclast differentiation invitro. RANKL
11  2016 Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity. GC
12  2016 ATF3 controls proliferation of osteoclast precursor and bone remodeling. ATF3, RANK
13  2016 Kavain Involvement in LPS-Induced Signaling Pathways. CAIA, hPBMC, WT
14  2016 Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways. AKAPs, cAMP, CTSK, LRP, PKA
15  2015 Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress. CASP2, ROS, SOD2, TRAP
16  2015 Echogenic perfluorohexane-loaded macrophages adhere in vivo to activated vascular endothelium in mice, an explorative study. PFH
17  2015 Hemeoxygenase-1 maintains bone mass via attenuating a redox imbalance in osteoclast. HO-1, OC, RANKL, ROS
18  2014 Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways. CsA, NFATc1, RANKL
19  2014 Differential expression of chemokines, chemokine receptors and proteinases by foreign body giant cells (FBGCs) and osteoclasts. CTSK, FBGCs, MIP-1alpha, MMP9, NFATc1, qPCR, RANKL, TRAP
20  2014 Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. RPM
21  2014 Inhibition of cathepsin activity in a cell-based assay by a light-activated ruthenium compound. ---
22  2014 Spatholobus suberectus inhibits osteoclastogenesis and stimulates chondrogenesis. MMP, OA, RANKL, SS, TIMP, TRAP
23  2013 Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass. AP-1, BM, CFU-GM, KO, M-CSF, MIF, NFATc1, OCLs, RANKL, TBV, TRAP, WT
24  2013 Luteolin inhibits inflammatory responses via p38/MK2/TTP-mediated mRNA stability. ELISA, IL-6, LPS, Lut, TNF-alpha
25  2013 Osteoporosis regulation by salubrinal through eIF2alpha mediated differentiation of osteoclast and osteoblast. BMD, NF-kappaB
26  2013 Pre-weaning growth hormone treatment ameliorates bone marrow macrophage inflammation in adult male rat offspring following maternal undernutrition. CS/UNS, GH, UN
27  2013 Targeted inhibition of phospholipase C gamma2 adaptor function blocks osteoclastogenesis and protects from pathological osteolysis. OCs, PLCgamma2, RANK, RANKL, SH2, WT
28  2012 Characterization and identification of subpopulations of mononuclear preosteoclasts induced by TNF-alpha in combination with TGF-beta in rats. MNCs
29  2012 Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation. Cldn-18, M-CSF, RANKL, TRAP5b, ZO-2
30  2012 Coptisine inhibits RANKL-induced NF-kappaB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. RANKL, RT-PCR
31  2012 Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-kappaB and ERK. GCT, LPS, RANKL
32  2012 The prostacyclin agonist iloprost aggravates fibrosis and enhances viral replication in enteroviral myocarditis by modulation of ERK signaling and increase of iNOS expression. CTGF, CVB, iNOS
33  2011 Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. ---
34  2009 Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity. CAPE, OCL, RANKL
35  2009 Pyridone 6, a pan-Janus-activated kinase inhibitor, suppresses osteoclast formation and bone resorption through down-regulation of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand (RANKL)-induced c-Fos and nuclear factor of activated T cells (NFAT) c1 expression. ERK, JAK, NF-kappaB, NFAT
36  2008 CSF-1 receptor structure/function in MacCsf1r-/- macrophages: regulation of proliferation, differentiation, and morphology. CSF-1R
37  2008 Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation. CGRP, CLR, CRSP, CTR, RAMP, RCP
38  2008 High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. CTR, d-Glc, DCF-DA, NF-kappaB, ROS, TRACP
39  2006 A signal through 4-1BB ligand inhibits receptor for activation of nuclear factor-kappaB ligand (RANKL)-induced osteoclastogenesis by increasing interferon (IFN)-beta production. 4-1BBL, IFN, M-CSF, MNC, RANKL, TRAP
40  2006 Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway. IL, OPG, RANKL
41  2003 Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population. IFN, M-CSF, RANKL
42  2002 CpG oligonucleotides: novel regulators of osteoclast differentiation. IL-1beta, TNF-alpha
43  2002 The generation of highly enriched osteoclast-lineage cell populations. CTR, M-CSF, RANKL, TGF-beta, TNF-alpha, TRAP
44  2001 Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs. CRP, SAP
45  2000 Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro. Con A, IL-1alpha, LPS
46  1999 Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages. MIP-1alpha
47  1999 SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages. CSF-1, SHP-1
48  1997 The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. CT
49  1997 The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide. Gal-lectin, iNOS, NO, TNF-alpha
50  1995 Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. CSF-1
51  1995 Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages. DFO, IL, LPS, TNF
52  1993 Cytokine expression from bone marrow derived macrophages. CM, CSF-1, G-CSF, GM-CSF, IL-3, IL-6, PWM, RIA
53  1991 Radiation leukemia virus (RadLV)-induced leukemogenesis is associated with an increased number and activity of thymic macrophages. ACP, OB, PL, RadLV, TLM, TM
54  1989 A positive feedback loop for staphylococcal enterotoxin-A-stimulated IFN-gamma production requires macrophage immune-associated antigen upregulation. Con A, Ia, IFN-gamma, PMA, SEA
55  1989 Control of lipoprotein lipase secretion in mouse macrophages. LPL